Akcea Therapeutics UK Ltd is an affiliate of Akcea Therapeutics Inc. Akcea is a biopharmaceutical company focused on transforming the lives of patients living with serious and rare diseases.
Our priority is to bring transformative medicines to patients by driving clinical program execution, understanding patient and physician needs, understanding the market, creating market access, and commercializing our products on a global basis.
We are driven by the knowledge that patients depend on us.
Akcea, an affiliate of Ionis Pharmaceuticals, was established in early 2015 and has a robust portfolio of development and registration-stage drugs covering multiple targets and diseases using advanced RNA-targeted antisense therapeutics. Akcea is building the infrastructure to commercialize its rugs globally and has its global headquarters located in Cambridge, Massachusetts.